We are live on ! Find out more
CFB

Cullen/Frost Bankers Portfolio holdings

AUM $10.1B
1-Year Est. Return 29.18%
This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+29.18%
3 Year Est. Return
+91.06%
5 Year Est. Return
+115.39%
10 Year Est. Return
+478.9%
AUM
$4.95B
AUM Growth
-$29.6M
Cap. Flow
-$37.3M
Cap. Flow %
-0.75%
Top 10 Hldgs %
26.9%
Holding
1,264
New
51
Increased
187
Reduced
349
Closed
44

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$16.3M
2
LRCX icon
Lam Research
LRCX
+$8.6M
3
TMO icon
Thermo Fisher Scientific
TMO
+$5.48M
4
PLD icon
Prologis
PLD
+$4.96M
5
KKR icon
KKR & Co
KKR
+$3.48M

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$13.2M
2
BSV icon
Vanguard Short-Term Bond ETF
BSV
+$9.37M
3
VZ icon
Verizon
VZ
+$8.94M
4
FCX icon
Freeport-McMoran
FCX
+$6.85M
5
AAPL icon
Apple
AAPL
+$5.53M

Sector Composition

Rank Sector Weight
1 Technology 22.28%
2 Financials 13.64%
3 Consumer Discretionary 10.89%
4 Healthcare 10.87%
5 Communication Services 9.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HEI.A icon
751
HEICO Corp Class A
HEI.A
$37.6B
$54K ﹤0.01%
458
– –
HLI icon
752
Houlihan Lokey
HLI
$8.68B
$54K ﹤0.01%
585
– –
TDG icon
753
TransDigm Group
TDG
$67.5B
$54K ﹤0.01%
86
– –
VER
754
DELISTED
VEREIT, Inc.
VER
$54K ﹤0.01%
1,200
– –
PAGS icon
755
PagSeguro Digital
PAGS
$2.46B
$53K ﹤0.01%
1,016
– –
UNM icon
756
Unum
UNM
$14.9B
$53K ﹤0.01%
2,100
– –
FDS icon
757
Factset
FDS
$9.97B
$52K ﹤0.01%
132
-54
-29% -$19.6K
GDV icon
758
Gabelli Dividend & Income Trust
GDV
$2.7B
$52K ﹤0.01%
2,010
– –
TPR icon
759
Tapestry
TPR
$26.3B
$52K ﹤0.01%
1,400
– –
NBIS
760
Nebius Group N.V.
NBIS
$72.3B
$52K ﹤0.01%
+652
New +$47.5K
AFB
761
AllianceBernstein National Municipal Income Fund
AFB
$317M
$51K ﹤0.01%
3,405
– –
OSK icon
762
Oshkosh
OSK
$9.54B
$51K ﹤0.01%
500
– –
STNE icon
763
StoneCo
STNE
$2.49B
$51K ﹤0.01%
1,458
– –
CIB icon
764
Grupo Cibest SA
CIB
$22.7B
$50K ﹤0.01%
1,458
– –
ENTG icon
765
Entegris
ENTG
$24.6B
$50K ﹤0.01%
394
– –
JRO
766
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$50K ﹤0.01%
5,000
– –
BXP icon
767
Boston Properties
BXP
$11.1B
$49K ﹤0.01%
448
– –
IBB icon
768
iShares Biotechnology ETF
IBB
$9.84B
$49K ﹤0.01%
300
– –
KMX icon
769
CarMax
KMX
$8.49B
$49K ﹤0.01%
381
– –
NEO icon
770
NeoGenomics
NEO
$2.14B
$49K ﹤0.01%
1,010
– –
ZWS icon
771
Zurn Elkay Water Solutions
ZWS
$8.45B
$49K ﹤0.01%
1,588
– –
CMS icon
772
CMS Energy
CMS
$22.1B
$48K ﹤0.01%
800
– –
DSGX icon
773
Descartes Systems
DSGX
$6.61B
$48K ﹤0.01%
596
– –
RGLD icon
774
Royal Gold
RGLD
$19.3B
$48K ﹤0.01%
+500
New +$56K
TREX icon
775
Trex
TREX
$5.14B
$48K ﹤0.01%
469
– –
29 30
31
32 33

Similar funds

RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.63% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
URS
Utah Retirement Systems Salt Lake City, Utah $9.78B AUM 28.72% 1-Year Est. Return

Cullen/Frost Bankers's Q3 2021 Portfolio in Review

As of Q3 2021, Cullen/Frost Bankers held 1,264 positions worth $4.95B, down 0.59% from $4.98B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Cullen/Frost Bankers's Q3 2021 filing shows 51 new, 187 increased, 349 reduced and 44 closed positions. Its largest new stake was KKR & Co: 55,414 shares worth $3.37M. The largest sale was Vertex Pharmaceuticals, an estimated $13.2M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Cullen/Frost Bankers's largest Q3 2021 buy was KKR & Co: 55,414 shares worth $3.37M.
  • Cullen/Frost Bankers added most to Chevron in Q3 2021, an estimated $16.3M increase.
  • Cullen/Frost Bankers's biggest Q3 2021 reduction was Vertex Pharmaceuticals, cutting an estimated $13.2M.
  • Cullen/Frost Bankers fully exited Maxim Integrated Products in Q3 2021, selling an estimated $1.24M.
  • Cullen/Frost Bankers's ten largest holdings make up 27% of its $4.95B portfolio in Q3 2021.
  • Cullen/Frost Bankers opened 51 new positions and closed 44 in Q3 2021.
  • Cullen/Frost Bankers's portfolio value fell 0.59% quarter-over-quarter to $4.95B.

Based on Cullen/Frost Bankers's 13F filing for Q3 2021, filed 4 Nov 2021.